Saxagliptin: A selective DPP-4 inhibitor for the treatment of type 2 diabetes mellitus

Jay Shubrook, Randall Colucci, Guo Aili, Frank Schwartz

Research output: Contribution to journalReview articlepeer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'Saxagliptin: A selective DPP-4 inhibitor for the treatment of type 2 diabetes mellitus'. Together they form a unique fingerprint.

Medicine & Life Sciences